Health Catalyst (HCAT) Rule 144: insider sale of 13,779 restricted shares

Rhea-AI Filing Summary

Health Catalyst, Inc. filed a Rule 144 notice to sell 13,779 shares of restricted common stock on 06/01/2026 described as compensation-related restricted stock. The filing lists an earlier restricted stock sale by Benjamin Landry on 03/02/2026 involving 20,838 shares and a figure 34,589 shown in the excerpt.

Insights

Securities Compliance Attorney

Rule 144 notice for restricted shares by a compensation recipient.

The filing lists the sale of 13,779 restricted shares of common stock on 06/01/2026 under Rule 144, identified as compensation-related. The record includes a prior restricted-stock entry for Benjamin Landry dated 03/02/2026 with 20,838 shares; the excerpt also shows 34,589 as an associated figure.

Rule 144 notices are administrative: they notify the market of an intended or completed sale under resale restrictions. Cash-flow treatment and ultimate sale mechanics are not specified in the provided excerpt; subsequent transfer or broker records would show execution details.

Key Figures

Rule 144 sale: 13,779 shares Prior restricted sale entry: 20,838 shares Associated figure shown: 34,589 +1 more

4 metrics

Rule 144 sale 13,779 shares 06/01/2026, restricted stock, compensation

Prior restricted sale entry 20,838 shares 03/02/2026, Benjamin Landry restricted stock entry

Associated figure shown 34,589 Appears in the excerpt alongside Benjamin Landry entries

Filing date shown 06/01/2026 Date tied to the 13,779-share restricted stock sale

Key Terms

Restricted Stock, Rule 144, Compensation

3 terms

Restricted Stock financial

"Restricted Stock | 06/01/2026 | Compensation"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Rule 144 regulatory

"144: Securities To Be Sold"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Compensation financial

"13779 | 06/01/2026 | Compensation"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC 1 New York Plaza, 38th Floor New York NY 10004	13779	18879.99	73894020	06/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/01/2026	Restricted Stock	Health Catalyst, Inc.			13779	06/01/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Benjamin Landry c/o 10897 South River From Parkway #100 South Jordan UT 84095	Restricted Stock	03/02/2026	20838	34589

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Health Catalyst's (HCAT) Form 144 disclose?

It discloses a Rule 144 notice to sell 13,779 restricted shares on 06/01/2026. The excerpt also shows a 03/02/2026 restricted-stock entry for Benjamin Landry with 20,838 shares and a figure 34,589.

Who is listed as a seller in the HCAT excerpt?

The excerpt lists Benjamin Landry with an address and a restricted-stock entry dated 03/02/2026 for 20,838 shares. The primary Rule 144 sale shows 13,779 shares on 06/01/2026 tied to compensation.

Does the Form 144 state how proceeds will be used for HCAT?

No. The excerpt labels the shares as compensation-related restricted stock and gives sale dates, but it does not state any use of proceeds or cash‑flow recipients in the provided text.

Are the listed shares sold or merely reported for resale under Rule 144?

The filing is a Rule 144 notice reporting resale of restricted shares; it lists 13,779 shares on 06/01/2026. The excerpt does not confirm whether the resale executed or remains planned.

What type of securities are covered in the HCAT excerpt?

The excerpt covers Common stock described as Restricted Stock, tied to compensation, with the primary quantity shown as 13,779 shares and date 06/01/2026.